CLINICAL TRIALS PROFILE FOR CLONIDINE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for clonidine hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00000279 ↗ | Novel Medications for Opiate Detoxification - 4 | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | 1994-09-01 | The purpose of this study is to evaluate novel medications for opiate detoxification. |
| NCT00000279 ↗ | Novel Medications for Opiate Detoxification - 4 | Completed | VA Connecticut Healthcare System | Phase 2 | 1994-09-01 | The purpose of this study is to evaluate novel medications for opiate detoxification. |
| NCT00000279 ↗ | Novel Medications for Opiate Detoxification - 4 | Completed | Yale University | Phase 2 | 1994-09-01 | The purpose of this study is to evaluate novel medications for opiate detoxification. |
| NCT00000800 ↗ | Methadone Effects on Zidovudine (ZDV, AZT) Disposition | Completed | Glaxo Wellcome | Phase 1 | 1969-12-31 | To determine whether methadone maintenance alters the pharmacokinetics of zidovudine (AZT). To determine whether any such effect of methadone on disposition of AZT is time dependent and whether a metabolic interaction between AZT and methadone exists. Injection drug users represent an increasing proportion of HIV-infected persons. Since daily methadone maintenance is the major chemical treatment for injection drug abuse, it is important to determine the impact of methadone on AZT absorption, distribution, and elimination. |
| NCT00000800 ↗ | Methadone Effects on Zidovudine (ZDV, AZT) Disposition | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | 1969-12-31 | To determine whether methadone maintenance alters the pharmacokinetics of zidovudine (AZT). To determine whether any such effect of methadone on disposition of AZT is time dependent and whether a metabolic interaction between AZT and methadone exists. Injection drug users represent an increasing proportion of HIV-infected persons. Since daily methadone maintenance is the major chemical treatment for injection drug abuse, it is important to determine the impact of methadone on AZT absorption, distribution, and elimination. |
| NCT00003771 ↗ | Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer | Completed | European Organisation for Research and Treatment of Cancer - EORTC | Phase 3 | 1997-09-01 | RATIONALE: Hormone replacement therapy is effective for relieving symptoms of menopause. It is not yet known if hormone replacement therapy increases the risk of breast cancer recurrence in women previously treated for early stage breast cancer. PURPOSE: Randomized phase III trial to determine the risk of breast cancer recurrence in women with previous early stage breast cancer who are receiving hormone replacement therapy for menopause symptoms. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for clonidine hydrochloride
Condition Name
Clinical Trial Locations for clonidine hydrochloride
Trials by Country
Clinical Trial Progress for clonidine hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for clonidine hydrochloride
Sponsor Name
